SlideShare a Scribd company logo
1 of 1
• Breast cancer is among the most prevalent of all cancers, second only to lung cancer.
• Mitochondrial morphological analyses of length shows the HTB-22 (adenocarcinoma)
displays a pro-fission phenotype with the shortest mitochondrial length observed.
• Breast cancer is among the most prevalent of all cancers, second only to lung cancer.
• Mitochondrial morphological analyses of length shows the HTB-22 (adenocarcinoma)
displays a pro-fission phenotype with the shortest mitochondrial length observed.
A Comparison of Mitochondrial Morphology in Breast Cancer Models
Zachary V. Gardner and Emily R. Roberts
Biological Sciences Department, Colorado Mesa University
A Comparison of Mitochondrial Morphology in Breast Cancer Models
Zachary V. Gardner and Emily R. Roberts
Biological Sciences Department, Colorado Mesa University
• Breast cancer is among the most prevalent of all cancers, second only to lung cancer.
• Mitochondria constantly undergo fusion and fission processes into longer and shorter
versions of these organelles, a process called mitochondrial dynamics.
• Mitochondrial dynamics and its role in breast cancer tumorigenesis is poorly characterized.
• This study investigated the dynamic nature of mitochondria and its role in human breast
cancer cell lines to determine how mitochondrial fusion and the fission influences cellular
death, including apoptosis, mitophagy, and survival (See Refs).
• Breast cancer is among the most prevalent of all cancers, second only to lung cancer.
• Mitochondria constantly undergo fusion and fission processes into longer and shorter
versions of these organelles, a process called mitochondrial dynamics.
• Mitochondrial dynamics and its role in breast cancer tumorigenesis is poorly characterized.
• This study investigated the dynamic nature of mitochondria and its role in human breast
cancer cell lines to determine how mitochondrial fusion and the fission influences cellular
death, including apoptosis, mitophagy, and survival (See Refs).
Figure 1. Mitochondrial dynamics showing fusion and fission via multi-protein pathways.
• Cancers exhibit an ability to evade apoptosis (controlled by the mitochondria).
• Mitochondrial fusion is linked to apoptotic inhibition (survival).
• Mitochondrial fission is essential for apoptosis (programmed cell death).
• As such, breast cancer models HTB-22 (adenocarcinoma) and HTB-126 (invasive ductal
carcinoma) should exhibit pro-fusion mitochondrial phenotypes when compared to HTB-
125 (non-tumorigenic lung epithelial cell) that will correlate with cancer cell survival.
• Cells were cultured in Opti-MEM with 10% fetal bovine serum and 5% CO2.
• Mitochondria were stained using Mitotracker Orange (Invitrogen), fixed with 4%
paraformaldehyde and visualized with the Texas Red filter using spinning disk confocal
microscopy (100x magnification).
• Mitochondrial length (N=94-96) measured in pixels using ImageJ software and converted
to microns using a corrective conversion factor (0.1402 µm/pixel).
• Statistical analyses: One-way ANOVA with Bonferroni post-tests.
HTB-125
HTB-126
HTB-22
MethodsMethods
Introduction
Hypothesis
Results
Conclusions
Future Directions
ReferencesReferences
• No significant differences in mitochondrial length were observed between the invasive
ductal carcinoma cells and the normal epithelial cells of the breast.
• HTB-126 did not show the hypothesized pro-fusion phenotype.
• The dynamic nature of mitochondria does not contribute to tumorigenesis of HTB-126
cells but the data supports a potential alteration of HTB-22 cells.
• Focus on adenocarcinoma (HTB-22) cells as they display a phenotype that could
potentially be influenced by alterations in mitochondrial dynamics.
• Examine post-fission mediated apoptotic signaling pathways that are controlled by the
pro-fission protein, Drp1 (Dynamin-related protein 1) via confocal microscopy and
Western blot analyses.
Figure 1. Thomas KJ and Cookson MR (2009). The Role of PTEN-induced Kinase 1 in
Mitochondrial Dysfunction and Dynamics. Int J Biochem Cell Biol. 41(10): 2025-35.
Figure 2.
http://www.bccancer.bc.ca/HPI/Nursing/Education/breastcancer/diagnosis/bcbasics.htm
Thomas KJ and MR Jacobson (2012). Defects in Mitochondrial Fission Protein Dynamin-
Related Protein 1 (Drp1) are Linked to Apoptotic Resistance and Autophagy in a Lung
Cancer Model. PLoS One. 7(9): e45319.
Roberts ER, Thomas KJ (2013). The Role of Mitochondria in the Development and
Progression of Lung Cancer. Comput Struct Biotechnol J. 6 (7): e201303019.
Figure 2. Breast Anatomy and Tumorigenic Conversion of its Cells.
TumorigenicConversion
HTB-125
HTB-22
HTB-126
HTB-22
HTB-125
HTB-126
Zoom of morphology
• Mentored by Dr. Kelly Jean Thomas Craig.
AcknowledgementAcknowledgement

More Related Content

What's hot

IGKC Presentation
IGKC PresentationIGKC Presentation
IGKC PresentationChaz874
 
Metastasis- Cancer cell migration
Metastasis- Cancer cell migrationMetastasis- Cancer cell migration
Metastasis- Cancer cell migrationQussai Abbas
 
Cancer stem cell dr.neelam ahirwar
Cancer stem cell dr.neelam ahirwarCancer stem cell dr.neelam ahirwar
Cancer stem cell dr.neelam ahirwarDr.Neelam Ahirwar
 
stem cell poster final
stem cell poster finalstem cell poster final
stem cell poster finalKhushbu Bhatt
 
Telomeric G-Quadruplexes as Therapeutic Targets in Cancer
Telomeric G-Quadruplexes as Therapeutic Targets in CancerTelomeric G-Quadruplexes as Therapeutic Targets in Cancer
Telomeric G-Quadruplexes as Therapeutic Targets in CancerHIRA Zaidi
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasisSandeep Kumar
 
Molecular mechanism of tumor invasiveness
Molecular mechanism of tumor invasivenessMolecular mechanism of tumor invasiveness
Molecular mechanism of tumor invasivenesstj1985
 
Dr. Hager Scholarship at Harvard (2012)
Dr. Hager Scholarship at Harvard (2012)Dr. Hager Scholarship at Harvard (2012)
Dr. Hager Scholarship at Harvard (2012)Dr. Martin Hager, MBA
 
Cancer stem cell theory and evidence from colorecatal
Cancer stem cell theory and evidence from colorecatalCancer stem cell theory and evidence from colorecatal
Cancer stem cell theory and evidence from colorecatalKareem Ahmed
 
Rectal cancer
Rectal cancerRectal cancer
Rectal cancerSpringer
 
Yang Poster 2015
Yang Poster 2015Yang Poster 2015
Yang Poster 2015Yang Cong
 
Immuotherapy 2
Immuotherapy 2Immuotherapy 2
Immuotherapy 2drmcbansal
 
Hallmarks of Cancer - Sustained Proliferative Signaling
Hallmarks of Cancer  - Sustained Proliferative SignalingHallmarks of Cancer  - Sustained Proliferative Signaling
Hallmarks of Cancer - Sustained Proliferative SignalingLiam Arnade-Colwill
 
GTC Group 4 Assignment
GTC Group 4 AssignmentGTC Group 4 Assignment
GTC Group 4 AssignmentCalvin Chan
 

What's hot (20)

IGKC Presentation
IGKC PresentationIGKC Presentation
IGKC Presentation
 
Metastasis- Cancer cell migration
Metastasis- Cancer cell migrationMetastasis- Cancer cell migration
Metastasis- Cancer cell migration
 
Cancer stem cell dr.neelam ahirwar
Cancer stem cell dr.neelam ahirwarCancer stem cell dr.neelam ahirwar
Cancer stem cell dr.neelam ahirwar
 
StntShwcs2015Abstract
StntShwcs2015AbstractStntShwcs2015Abstract
StntShwcs2015Abstract
 
stem cell poster final
stem cell poster finalstem cell poster final
stem cell poster final
 
Telomeric G-Quadruplexes as Therapeutic Targets in Cancer
Telomeric G-Quadruplexes as Therapeutic Targets in CancerTelomeric G-Quadruplexes as Therapeutic Targets in Cancer
Telomeric G-Quadruplexes as Therapeutic Targets in Cancer
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasis
 
Molecular mechanism of tumor invasiveness
Molecular mechanism of tumor invasivenessMolecular mechanism of tumor invasiveness
Molecular mechanism of tumor invasiveness
 
Report CTX 2015
Report CTX 2015Report CTX 2015
Report CTX 2015
 
Dr. Hager Scholarship at Harvard (2012)
Dr. Hager Scholarship at Harvard (2012)Dr. Hager Scholarship at Harvard (2012)
Dr. Hager Scholarship at Harvard (2012)
 
Cancer stem cell theory and evidence from colorecatal
Cancer stem cell theory and evidence from colorecatalCancer stem cell theory and evidence from colorecatal
Cancer stem cell theory and evidence from colorecatal
 
Hallmarks in cancer
Hallmarks in cancerHallmarks in cancer
Hallmarks in cancer
 
Hallmarks of cancer
Hallmarks of cancerHallmarks of cancer
Hallmarks of cancer
 
Rectal cancer
Rectal cancerRectal cancer
Rectal cancer
 
Yang Poster 2015
Yang Poster 2015Yang Poster 2015
Yang Poster 2015
 
Diploma Thesis - Abstract
Diploma Thesis - AbstractDiploma Thesis - Abstract
Diploma Thesis - Abstract
 
Immuotherapy 2
Immuotherapy 2Immuotherapy 2
Immuotherapy 2
 
Cancer
CancerCancer
Cancer
 
Hallmarks of Cancer - Sustained Proliferative Signaling
Hallmarks of Cancer  - Sustained Proliferative SignalingHallmarks of Cancer  - Sustained Proliferative Signaling
Hallmarks of Cancer - Sustained Proliferative Signaling
 
GTC Group 4 Assignment
GTC Group 4 AssignmentGTC Group 4 Assignment
GTC Group 4 Assignment
 

Viewers also liked

Lorin - case study so far
Lorin - case study so farLorin - case study so far
Lorin - case study so farcitizenschools
 
CA 3.02 Flat Earth to Sphere
CA 3.02 Flat Earth to SphereCA 3.02 Flat Earth to Sphere
CA 3.02 Flat Earth to SphereStephen Kwong
 
PCR and its types
PCR and  its typesPCR and  its types
PCR and its typessujathar23
 

Viewers also liked (6)

Lorin - case study so far
Lorin - case study so farLorin - case study so far
Lorin - case study so far
 
CA 3.02 Flat Earth to Sphere
CA 3.02 Flat Earth to SphereCA 3.02 Flat Earth to Sphere
CA 3.02 Flat Earth to Sphere
 
real time-PCR..
real time-PCR..real time-PCR..
real time-PCR..
 
Real time PCR
Real time PCRReal time PCR
Real time PCR
 
Mitochondria Research Focus
Mitochondria Research FocusMitochondria Research Focus
Mitochondria Research Focus
 
PCR and its types
PCR and  its typesPCR and  its types
PCR and its types
 

Similar to ZG_SS14_pageformat

Cancer chemotherapy for medical students
Cancer chemotherapy for medical studentsCancer chemotherapy for medical students
Cancer chemotherapy for medical studentstaklo simeneh
 
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer Therapeutics
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer TherapeuticsCytokine Immunotherapy: A Forthcoming Visible Feature in Cancer Therapeutics
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer TherapeuticsSachin K. S. Chauhan
 
Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)soumik1997
 
2014 Sigma Xi PowerPoint Presentation
2014 Sigma Xi PowerPoint Presentation2014 Sigma Xi PowerPoint Presentation
2014 Sigma Xi PowerPoint PresentationEmily05
 
24 janvier CROQUER LA VIE - Dr Thomas Seyfried
24 janvier CROQUER LA VIE - Dr Thomas Seyfried24 janvier CROQUER LA VIE - Dr Thomas Seyfried
24 janvier CROQUER LA VIE - Dr Thomas Seyfriedcroquer_la_vie
 
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted MoleculeCancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted Moleculeijtsrd
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...M. Luisetto Pharm.D.Spec. Pharmacology
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationJayden On
 
Plegable power point presentation
Plegable power point presentation Plegable power point presentation
Plegable power point presentation santiagorc5
 
Breast til journal club presentation pot
Breast til journal club presentation potBreast til journal club presentation pot
Breast til journal club presentation potTanyaAgarwal471511
 
Oncology section a
Oncology section aOncology section a
Oncology section aMUBOSScz
 
Melissa Shadoin - INBRE Conference 2015 FINAL
Melissa Shadoin - INBRE Conference 2015 FINALMelissa Shadoin - INBRE Conference 2015 FINAL
Melissa Shadoin - INBRE Conference 2015 FINALMelissa Shadoin
 
Proteasome inhibitors in cancer therapy
Proteasome inhibitors in cancer therapyProteasome inhibitors in cancer therapy
Proteasome inhibitors in cancer therapyMohd Uzair Ansari
 
immunotherapy for multiple myeloma
immunotherapy for multiple myelomaimmunotherapy for multiple myeloma
immunotherapy for multiple myelomaspa718
 
A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...Shashaanka Ashili
 
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
 
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...Vorinostat combined with DNMTi epigenetically controls the proliferation of l...
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...MustafaFathy6
 

Similar to ZG_SS14_pageformat (20)

Cancer chemotherapy for medical students
Cancer chemotherapy for medical studentsCancer chemotherapy for medical students
Cancer chemotherapy for medical students
 
Real ROCH
Real ROCHReal ROCH
Real ROCH
 
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer Therapeutics
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer TherapeuticsCytokine Immunotherapy: A Forthcoming Visible Feature in Cancer Therapeutics
Cytokine Immunotherapy: A Forthcoming Visible Feature in Cancer Therapeutics
 
Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)
 
2014 Sigma Xi PowerPoint Presentation
2014 Sigma Xi PowerPoint Presentation2014 Sigma Xi PowerPoint Presentation
2014 Sigma Xi PowerPoint Presentation
 
24 janvier CROQUER LA VIE - Dr Thomas Seyfried
24 janvier CROQUER LA VIE - Dr Thomas Seyfried24 janvier CROQUER LA VIE - Dr Thomas Seyfried
24 janvier CROQUER LA VIE - Dr Thomas Seyfried
 
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted MoleculeCancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...
 
9. neoplasia 2
9. neoplasia 29. neoplasia 2
9. neoplasia 2
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 Presentation
 
Plegable power point presentation
Plegable power point presentation Plegable power point presentation
Plegable power point presentation
 
Breast til journal club presentation pot
Breast til journal club presentation potBreast til journal club presentation pot
Breast til journal club presentation pot
 
Oncology section a
Oncology section aOncology section a
Oncology section a
 
Melissa Shadoin - INBRE Conference 2015 FINAL
Melissa Shadoin - INBRE Conference 2015 FINALMelissa Shadoin - INBRE Conference 2015 FINAL
Melissa Shadoin - INBRE Conference 2015 FINAL
 
Proteasome inhibitors in cancer therapy
Proteasome inhibitors in cancer therapyProteasome inhibitors in cancer therapy
Proteasome inhibitors in cancer therapy
 
immunotherapy for multiple myeloma
immunotherapy for multiple myelomaimmunotherapy for multiple myeloma
immunotherapy for multiple myeloma
 
A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...
 
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...
 
Antibody Drug Conjugates
Antibody Drug ConjugatesAntibody Drug Conjugates
Antibody Drug Conjugates
 
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...Vorinostat combined with DNMTi epigenetically controls the proliferation of l...
Vorinostat combined with DNMTi epigenetically controls the proliferation of l...
 

ZG_SS14_pageformat

  • 1. • Breast cancer is among the most prevalent of all cancers, second only to lung cancer. • Mitochondrial morphological analyses of length shows the HTB-22 (adenocarcinoma) displays a pro-fission phenotype with the shortest mitochondrial length observed. • Breast cancer is among the most prevalent of all cancers, second only to lung cancer. • Mitochondrial morphological analyses of length shows the HTB-22 (adenocarcinoma) displays a pro-fission phenotype with the shortest mitochondrial length observed. A Comparison of Mitochondrial Morphology in Breast Cancer Models Zachary V. Gardner and Emily R. Roberts Biological Sciences Department, Colorado Mesa University A Comparison of Mitochondrial Morphology in Breast Cancer Models Zachary V. Gardner and Emily R. Roberts Biological Sciences Department, Colorado Mesa University • Breast cancer is among the most prevalent of all cancers, second only to lung cancer. • Mitochondria constantly undergo fusion and fission processes into longer and shorter versions of these organelles, a process called mitochondrial dynamics. • Mitochondrial dynamics and its role in breast cancer tumorigenesis is poorly characterized. • This study investigated the dynamic nature of mitochondria and its role in human breast cancer cell lines to determine how mitochondrial fusion and the fission influences cellular death, including apoptosis, mitophagy, and survival (See Refs). • Breast cancer is among the most prevalent of all cancers, second only to lung cancer. • Mitochondria constantly undergo fusion and fission processes into longer and shorter versions of these organelles, a process called mitochondrial dynamics. • Mitochondrial dynamics and its role in breast cancer tumorigenesis is poorly characterized. • This study investigated the dynamic nature of mitochondria and its role in human breast cancer cell lines to determine how mitochondrial fusion and the fission influences cellular death, including apoptosis, mitophagy, and survival (See Refs). Figure 1. Mitochondrial dynamics showing fusion and fission via multi-protein pathways. • Cancers exhibit an ability to evade apoptosis (controlled by the mitochondria). • Mitochondrial fusion is linked to apoptotic inhibition (survival). • Mitochondrial fission is essential for apoptosis (programmed cell death). • As such, breast cancer models HTB-22 (adenocarcinoma) and HTB-126 (invasive ductal carcinoma) should exhibit pro-fusion mitochondrial phenotypes when compared to HTB- 125 (non-tumorigenic lung epithelial cell) that will correlate with cancer cell survival. • Cells were cultured in Opti-MEM with 10% fetal bovine serum and 5% CO2. • Mitochondria were stained using Mitotracker Orange (Invitrogen), fixed with 4% paraformaldehyde and visualized with the Texas Red filter using spinning disk confocal microscopy (100x magnification). • Mitochondrial length (N=94-96) measured in pixels using ImageJ software and converted to microns using a corrective conversion factor (0.1402 µm/pixel). • Statistical analyses: One-way ANOVA with Bonferroni post-tests. HTB-125 HTB-126 HTB-22 MethodsMethods Introduction Hypothesis Results Conclusions Future Directions ReferencesReferences • No significant differences in mitochondrial length were observed between the invasive ductal carcinoma cells and the normal epithelial cells of the breast. • HTB-126 did not show the hypothesized pro-fusion phenotype. • The dynamic nature of mitochondria does not contribute to tumorigenesis of HTB-126 cells but the data supports a potential alteration of HTB-22 cells. • Focus on adenocarcinoma (HTB-22) cells as they display a phenotype that could potentially be influenced by alterations in mitochondrial dynamics. • Examine post-fission mediated apoptotic signaling pathways that are controlled by the pro-fission protein, Drp1 (Dynamin-related protein 1) via confocal microscopy and Western blot analyses. Figure 1. Thomas KJ and Cookson MR (2009). The Role of PTEN-induced Kinase 1 in Mitochondrial Dysfunction and Dynamics. Int J Biochem Cell Biol. 41(10): 2025-35. Figure 2. http://www.bccancer.bc.ca/HPI/Nursing/Education/breastcancer/diagnosis/bcbasics.htm Thomas KJ and MR Jacobson (2012). Defects in Mitochondrial Fission Protein Dynamin- Related Protein 1 (Drp1) are Linked to Apoptotic Resistance and Autophagy in a Lung Cancer Model. PLoS One. 7(9): e45319. Roberts ER, Thomas KJ (2013). The Role of Mitochondria in the Development and Progression of Lung Cancer. Comput Struct Biotechnol J. 6 (7): e201303019. Figure 2. Breast Anatomy and Tumorigenic Conversion of its Cells. TumorigenicConversion HTB-125 HTB-22 HTB-126 HTB-22 HTB-125 HTB-126 Zoom of morphology • Mentored by Dr. Kelly Jean Thomas Craig. AcknowledgementAcknowledgement